The World Health Organization (WHO) has declared a global health emergency due to a new, more virulent strain of mpox, known as clade 1b, originating from the Democratic Republic of Congo (DRC). This variant has led to over 17,000 new infections and 517 deaths, spreading rapidly to Europe and Asia. Scientists are concerned about the disease's asymptomatic transmission, which complicates tracking and containment efforts. Despite the alarming spread, experts like Dr. Cheryl Walter reassure that a lockdown is unlikely due to existing vaccines and antiviral treatments. Vaccine manufacturers, such as Bavarian Nordic, have seen a surge in stock prices as they ramp up production to meet anticipated demand. The DRC government reports a pressing need for 3.5 million vaccine doses to halt the outbreak, calling for international assistance.